Net Asset Value
As of Dec 16, 2020
YTD Return
As of Dec 16, 2020
1 Day NAV Change
$0.05 (1.44%)
As of Dec 16, 2020
YTD Return
As of Dec 16, 2020
Key Features
Exposure to Innovation

Aims for thematic multi-cap exposure to innovation across sectors. ARK believes the securities held in ARKK present the best risk-reward opportunities from ARK’s innovation-based themes.

Growth Potential

Aims to capture long-term growth with low correlation of relative returns to traditional growth strategies and negative correlation to value strategies.

Tool for Diversification

Offers a tool for diversification due to little overlap with traditional indices. It can be a complement to traditional value/growth strategies.

Grounded in Research

Combines top-down and bottom-up research in its portfolio management to identify innovative companies and convergence across markets.

Cost Effective

Provides a lower cost alternative to mutual funds with true active management in an Exchange Traded Fund (ETF) that invests in rapidly moving themes.

Get Full Information
Fund Details
As of 30/11/2020
  • FUND AUM$8.9 Billion
  • TYPEActive Equity ETF
  • CUSIP00214Q 104
  • INCEPTION DATE10/31/2014
  • WEIGHTED AVG. MARKET CAP.$76.3 Billion
  • MEDIAN MARKET CAP.$5.9 Billion
  • ADVISORARK Investment Management LLC
  • SALES SERVICES Resolute Investment Distributors, Inc.
  • FUND DISTRIBUTOR Foreside Fund Services, LLC
NAV Historical Change
As of Dec 16, 2020
NAV and Market Price
  • NAV$113.19
  • NAV Change$0.05 | 2.61%
  • Median Bid/Ask Spead (30 Day)3.35%
  • Market Price$113.34
  • Market Price Change$4.04 | 3.17%
  • Day’s Trading Volume6,958,920 shares
ARKK Performance
As of Dec 16, 2020
ARKK 1 Months 3 Months YTD 1 Year 3 Years 5 Years Since Inception
NAV 26.28% 29.18% 83.72% 115.18% 41.49% 39.20% 30.97%
Market Price 26.16% 29.01% 83.82% 115.30% 41.21% 39.37% 30.98%


Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The 
investment return and principal will fluctuate so that an investor’s shares when redeemed may be worth more or less than the original cost. The Fund’s most recent month-end performance can be found in the fund material section. Returns for less than one year are not annualized. Net asset value (“NAV”) returns are based on the dollar value of a single share of the ETF, calculated using the value of the underlying assets of the ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the New York Stock Exchange is open for trading. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times. Total Return reflects reinvestment of distributions on ex-date for NAV returns and payment date for Market Price returns. The market price of the ETF’s shares may differ significantly from their NAV during periods of market volatility.

Top 10 Holdings
As of Dec 16, 2020
Full Holdings
Ticker Name Sector Asset Class Market Value Weight (%) Notional Value
TSLA Crispr Therapeutics AG Consumer Discretionary Equity $1,048,954,964 7.05% $1,048,954,964
TSLA Crispr Therapeutics AG Consumer Discretionary Equity $1,048,954,964 8.05% $1,048,954,964
TSLA Crispr Therapeutics AG Consumer Discretionary Equity $1,048,954,964 7.05% $1,048,954,964
TSLA Crispr Therapeutics AG Consumer Discretionary Equity $1,048,954,964 8.05% $1,048,954,964
TSLA Crispr Therapeutics AG Consumer Discretionary Equity $1,048,954,964 7.05% $1,048,954,964
TSLA Crispr Therapeutics AG Consumer Discretionary Equity $1,048,954,964 8.05% $1,048,954,964
TSLA Crispr Therapeutics AG Consumer Discretionary Equity $1,048,954,964 7.05% $1,048,954,964
TSLA Crispr Therapeutics AG Consumer Discretionary Equity $1,048,954,964 8.05% $1,048,954,964
Exposure Breakdowns
As of 12/16/2020
Fund % of Market Value
United States
United States
United States
United Kingdom

Investors should carefully consider the investment objectives and risks as well as charges and expenses of an ARK ETF before investing. This and other information are contained in the ARK ETFs' prospectuses, which may be obtained by clicking here. The prospectus should be read carefully before investing. An investment in an ARK ETF is subject to risks and you can lose money on your investment in an ARK ETF. There can be no assurance that the ARK ETFs will achieve their investment objectives. The ARK ETFs’ portfolios are more volatile than broad market averages. The ARK ETFs also have specific risks, which are described in the ARK ETFs' prospectuses.

Find your way
Fund Documents
Fact Sheet
Summary Prospectus
Fund Holdings PDF
Fund Holdings CSV
Quarterly Report
Semi-Annual Report
Annual Report
Recent Premium/Discount
As of Dec 16, 2020
Select time period
Historical Data
Greatest Premium: 0.08%(10/8/2020)
Greatest Discount: -0.50% (12/18/2020)
Number of Days At
  • Premium:37
  • NAV:19
  • Discount:10
Days Within Percent of NAV
  • Percent of Days ± 0.5% of NAV:100%
  • Number of Days ± 0.5% of NAV:57

The Premium/Discount chart shows the difference between the daily market price of the Fund’s shares and the Fund’s net asset value (“NAV”). The daily market price is calculated using the mid-point between the highest bid and the lowest offer on the listing exchange, as of the time that the Fund’s NAV is calculated (usually 4:00 pm Eastern time). The vertical axis of the chart shows the premium or discount of the Mid-Point price as a percentage of the NAV. The horizontal axis shows the number of trading days covered by the chart, and each bar in the chart demonstrates how many days the Fund traded within the given premium/discount range. The data presented in the chart and table above represent past performance and cannot be used to predict future results.


Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information are contained in the prospectus. Please read the prospectus carefully before investing.

The principal risks of investing in the ARKK include: Equity Securities Risk. The value of the equity securities the Fund holds may fall due to general market and economic conditions. Health Care Sector Risk. The health care sector may be adversely affected by government regulations and government health care programs. Industrials Sector Risk. Companies in the industrials sector may be adversely affected by changes in government regulation, world events, economic conditions, environmental damages, product liability claims and exchange rates. Information Technology Sector Risk. Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins. Cryptocurrency Risk. Cryptocurrency (notably, bitcoin), often referred to as ‘‘virtual currency’’ or ‘‘digital currency,’’ operates as a decentralized, peer-to-peer financial exchange and value storage that is used like money. The Fund may have exposure to bitcoin, a cryptocurrency, indirectly through an investment in the Bitcoin Investment Trust (‘‘GBTC’’), a privately offered, open-end investment vehicle. Cryptocurrency operates without central authority or banks and is not backed by any government. Even indirectly, cryptocurrencies may experience very high volatility and related investment vehicles like GBTC may be affected by such volatility. As a result of holding cryptocurrency, the Fund may also trade at a significant premium to NAV. Cryptocurrency is also not legal tender. Federal, state or foreign governments may restrict the use and exchange of cryptocurrency, and regulation in the U.S. is still developing. Cryptocurrency exchanges may stop operating or permanently shut down due to fraud, technical glitches, hackers or malware. Additional risks of investing in ARKK include foreign securities, market, management and non-diversification risks. Detailed information regarding the specific risks of ARKK can be found in the ETF’s prospectus.

Portfolio holdings will change and should not be considered as investment advice or a recommendation to buy, sell or hold any particular security.

Award Disclosure

[1] Other Finalists “Active ETF of the Year” 2018: TrimTabs All Cap U.S. Free-Cash-Flow ETF (TTAC), WBI BullBear Yield 1000 ETF (WBIG), WisdomTree U.S. Quality Shareholder Yield Fund (QSY); | Methodology: Ranking Entity: Fund Intelligence; Length of the period: 12 Months; Criteria on which the ranking is based: The winners are comprised of the individuals and firms who have been nominated via the online submission process and through recommendations from market participants. Judges will use the submitted application material, as well as any uploaded supplemental information, to make a determination on the firm, individual or product they believe to be the most suitable and deserving winners for each category. The Judges’ Choice Awards are adjudicated by a panel of industry experts convened by the Fund Action and Fund Directions editorial teams. The industry judges contribute their sector expertise to debate the merits of shortlist candidates to come to a decision on the winners. (Award Page:

You are leaving
By clicking below you acknowledge that you are navigating away from and will be connected to ARK Investment Management LLC manages both web domains. Please take note of ARK’s privacy policy, terms of use, and disclosures that may vary between sites.